The Scientist

» industry and genetics & genomics

Most Recent

image: Do Patents Promote or Stall Innovation?

Do Patents Promote or Stall Innovation?

By | June 1, 2016

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

3 Comments

image: Finding Mislabeled Noncoding RNAs

Finding Mislabeled Noncoding RNAs

By | June 1, 2016

Researchers scour the genome for micropeptides encoded within RNAs presumed to function in a noncoding capacity.

0 Comments

image: Questions Over <em>C. elegans</em> Life Span Factors

Questions Over C. elegans Life Span Factors

By | June 1, 2016

A recent paper challenges earlier findings that germline factors expressed in normal body cells influence life span in C. elegans.

0 Comments

image: Research at Micro- and Nanoscales

Research at Micro- and Nanoscales

By | June 1, 2016

From whole cells to genes, closer examination continues to surprise.  

1 Comment

image: Screening  with CRISPR

Screening with CRISPR

By | June 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Noncoding RNAs Not So Noncoding

Noncoding RNAs Not So Noncoding

By | June 1, 2016

Bits of the transcriptome once believed to function as RNA molecules are in fact translated into small proteins.

4 Comments

image: Synthetic Biology Comes into Its Own

Synthetic Biology Comes into Its Own

By | June 1, 2016

Researchers create novel genetic circuits that give insight into, and are inspired by, nature.

0 Comments

image: E.U. Delays Vote on Roundup

E.U. Delays Vote on Roundup

By | May 24, 2016

Newly published research on the key ingredient in the Monsanto-made weed killer is holding up lawmakers’ decisions on whether to continue to allow its sale in Europe.

4 Comments

The US Department of Agriculture orders Santa Cruz Biotechnology to pay a $3.5 million fine and to cease selling research antibodies.

0 Comments

image: Pfizer Scoops Anacor for $5.3 Billion

Pfizer Scoops Anacor for $5.3 Billion

By | May 17, 2016

The acquisition-hungry pharmaceutical firm is purchasing the California-based eczema gel maker.

0 Comments

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. Search for Life on the Red Planet
FreeShip